Novo sheds 13,000 jobs in a year
- Posted on September 21, 2026
- By Financial Times
- 1 Views
- 1 min read
In brief
Novo Nordisk implements significant workforce reduction affecting 13,000 employees within twelve months. The Danish pharmaceutical giant confronts intense market pressures demanding enhanced financial performance and increased profitability. This strategic restructuring reflects the company's effort to optimize operational efficiency while navigating competitive dynamics in the global pharmaceutical sector and growing demand for weight-loss medications.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
Novo sheds 13,000 jobs in a year
Danish maker of weight-loss drugs is under pressure to boost revenues and profits
